Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ INVESTOR DEADLINE AUGUST 25: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity... (PR Newswire) +++ SAREPTA Aktie +5,13%

CARDLYTICS Aktie

 >CARDLYTICS Aktienkurs 
0.86 EUR    -4.1%    (Tradegate)
Ask: 0.892 EUR / 16820 Stück
Bid: 0.8572 EUR / 17500 Stück
Tagesumsatz: 3700 Stück
Realtime Kurs von 8 bis 22 Uhr!
CARDLYTICS Aktie über LYNX handeln
>CARDLYTICS Performance
1 Woche: -18,5%
1 Monat: -46,2%
3 Monate: -49,2%
6 Monate: -68,5%
1 Jahr: -75,9%
laufendes Jahr: -75,7%
>CARDLYTICS Aktie
Name:  CARDLYTICS INC DL-,0001
Land:  USA
Sektor:  Dienstleistungen
ISIN/ Wkn:  US14161W1053 / A2JDMC
Symbol/ Ticker:  CYX (Frankfurt) / CDLX (NASDAQ)
Kürzel:  FRA:CYX, ETR:CYX, CYX:GR, NASDAQ:CDLX
Index:  -
Webseite:  https://www.cardlytics.co..
Profil:  Cardlytics Inc. is a digital advertising platform ..
>Volltext..
Marktkapitalisierung:  50.26 Mio. EUR
Unternehmenswert:  197.58 Mio. EUR
Umsatz:  228.45 Mio. EUR
EBITDA:  -25.54 Mio. EUR
Nettogewinn:  -157.34 Mio. EUR
Gewinn je Aktie:  -3.12 EUR
Schulden:  189.16 Mio. EUR
Liquide Mittel:  40.12 Mio. EUR
Operativer Cashflow:  -1.04 Mio. EUR
Bargeldquote:  0.36
Umsatzwachstum:  -20.75%
Gewinnwachstum:  -8.72%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  3 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 638.043 USD.
Suchwörter:  CARDLYTICS
Letzte Datenerhebung:  21.08.25
>CARDLYTICS Kennzahlen
Aktien/ Unternehmen:
Aktien: 53.24 Mio. St.
Frei handelbar: 94.8%
Rückkaufquote: 0.18%
Mitarbeiter: 454
Umsatz/Mitarb.: 0.53 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 51.93%
Bewertung:
KGV: -
KGV lG: -
KUV: 0.22
KBV: 0.98
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: 45.16%
Gewinnmarge: -68.87%
Operative Marge: -21.41%
Managementeffizenz:
Gesamtkaprendite: -40.95%
Eigenkaprendite: -136.44%
>CARDLYTICS Peer Group

Es sind 295 Aktien bekannt.
 
20.08.25 - 05:01
Insiderhandel: Chief Executive Officer verkauft Aktien von Cardlytics im Wert von 76790 USD (Insiderkauf)
 
Gupta, Amit - Vorstand - Tag der Transaktion: 2025-08-19...
20.08.25 - 05:01
Insiderhandel: Chief Executive Officer verkauft Aktien von Cardlytics im Wert von 76793 USD (Insiderkauf)
 
Gupta, Amit - Vorstand - Tag der Transaktion: 2025-08-18...
20.08.25 - 05:01
Insiderhandel: Insider verkauft Aktien von Cardlytics im Wert von 224540 USD (Insiderkauf)
 
Sosin, Clifford - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2025-08-19...
20.08.25 - 05:01
Insiderhandel: Insider verkauft Aktien von Cardlytics im Wert von 228220 USD (Insiderkauf)
 
Sosin, Clifford - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2025-08-18...
19.08.25 - 01:01
Insiderhandel: Chief Financial Officer verkauft Aktien von Cardlytics im Wert von 31700 USD (Insiderkauf)
 
Desieno, Alexis - Vorstand - Tag der Transaktion: 2025-08-15...
07.08.25 - 07:00
Cardlytics (CDLX) Q2 Users Jump 19% (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
07.08.25 - 02:24
Cardlytics signals up to $95M Q3 billings amid major FI partner content restrictions (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.08.25 - 01:45
Cardlytics (CDLX) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
 
Cardlytics (CDLX) delivered earnings and revenue surprises of +18.75% and -0.86%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?...
06.08.25 - 22:06
Cardlytics Announces Second Quarter 2025 Financial Results (Business Wire)
 
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX), a commerce media platform, today announced financial results for the second quarter ended June 30, 2025. "Building on the progress we've made over the past year, we are navigating headwinds by doubling down on our diversification efforts and reinforcing our unique network capabilities," said Amit Gupta, CEO of Cardlytics. "We believe our strategic shifts will position us for long-term profitable growth and enable us to deliver on the promise to our stakeholders." Second Quarter 2025 Financial Results Revenue was $63.2 million, a decrease of 9% year-over-year compared to $69.6 million in the second quarter of 2024. Billings, a non-GAAP metric, was $104.0 million, a decrease of 6% year-over-year compared to $110.4 million in the second quarter of 2024. Adjusted Contribution, a non-GAAP metric, was $36.1 million, a decrease of 1% year-over-year compared to $36.4 million in the second quarter of 2024. Net Loss was $(9.3) million, ...
01.08.25 - 22:09
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
 
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on July 30, 2025, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 454,600 restricted stock units of Cardlytics to two newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”). For all of the grant recipients, 50% of the restricted stock units shall vest on the first anniversary of the grant date, and the remaining 50% shall vest quarterly over the subsequent 12 months, subject to the employees' continuous service with Cardlytics through the vesting date. The restricted stock units are subject to the terms and conditions of the 2022 Inducement Plan. About Cardlytics Cardlytics (NASDAQ: CDLX) is a commerce media platform, powered by our publishers' first-party purchase data, that makes ...
23.07.25 - 22:06
Cardlytics Announces Timing of Its Second Quarter 2025 Earnings Release (Business Wire)
 
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that its financial results for the second quarter ending June 30, 2025 will be released on August 6, 2025, after market close. Conference Call Details: When: August 6, 2025 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access the live audio webcast on the Cardlytics Investor Relations website at ir.cardlytics.com, or by registering at this link. Following the call, a replay will be available on the website. Dial-in: Call participants may dial +1 800-549-8228 and use Conference ID: 14299. About Cardlytics Cardlytics (NASDAQ: CDLX) is a commerce media platform, powered by our publishers' first-party purchase data, that makes commerce smarter and more rewarding for everyone. We offer a range of solutions to help advertisers and publishers grow and strengthen customer loyalty. With visibility into approximately half of all card-based transactions in the U.S. and a quarter in the U.K., Cardlytics enables advertis...
03.07.25 - 07:02
Insiderhandel: Chief Legal & Privacy Officer verkauft Aktien von Cardlytics im Wert von 9396 USD (Insiderkauf)
 
Lynton, Nicholas Hollmeyer - Vorstand - Tag der Transaktion: 2025-07-02...
03.07.25 - 07:02
Insiderhandel: Chief Financial Officer verkauft Aktien von Cardlytics im Wert von 13056 USD (Insiderkauf)
 
Desieno, Alexis - Vorstand - Tag der Transaktion: 2025-07-02...
03.07.25 - 07:02
Insiderhandel: Chief Executive Officer verkauft Aktien von Cardlytics im Wert von 11988 USD (Insiderkauf)
 
Gupta, Amit - Vorstand - Tag der Transaktion: 2025-07-02...
17.05.25 - 01:01
Insiderhandel: Chief Financial Officer verkauft Aktien von Cardlytics im Wert von 50809 USD (Insiderkauf)
 
Desieno, Alexis - Vorstand - Tag der Transaktion: 2025-05-15...
08.05.25 - 04:57
Cardlytics outlines platform expansion with new partners and CRP launch in Q2 2025 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
08.05.25 - 02:30
Cardlytics (CDLX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
 
Cardlytics (CDLX) delivered earnings and revenue surprises of 22.22% and 7.46%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?...
07.05.25 - 22:06
Cardlytics Announces First Quarter 2025 Financial Results (Business Wire)
 
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced financial results for the first quarter ended March 31, 2025. "We've made marked progress across our key business pillars, which continue to underpin our journey to 'platformize' Cardlytics and position ourselves as the leading commerce media platform," said Amit Gupta, CEO of Cardlytics. "Our expanding ecosystem, depth and breadth of our data, and ongoing tech investments are strengthening our position and providing differentiated value to our partners and advertisers." "We've built a resilient platform and are making strategic decisions as we look to future-proof our business," said Alexis DeSieno, CFO of Cardlytics. "With recent actions to strengthen our balance sheet, we're taking a targeted, disciplined approach to cost management while continuing to invest in key areas for growth.” First Quarter 2025 Financial Results Revenue was $61.9 million, a decrea...
25.04.25 - 22:06
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
 
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on April 24, 2025, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 124,050 restricted stock units of Cardlytics to 11 newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”). For all of the grant recipients, 50% of the restricted stock units shall vest on the first anniversary of the grant date, and the remaining 50% shall vest quarterly over the subsequent 12 months, subject to the employees' continuous service with Cardlytics through the vesting date. The restricted stock units are subject to the terms and conditions of the 2022 Inducement Plan. About Cardlytics Cardlytics (NASDAQ: CDLX) is a commerce media platform, powered by our publishers' first-party purchase data, that makes ...
23.04.25 - 22:12
Cardlytics Announces Timing of Its First Quarter 2025 Earnings Release (Business Wire)
 
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that its financial results for the first quarter ending March 31, 2025 will be released on May 7, 2025, after market close. Conference Call Details: When: May 7, 2025 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access the live audio webcast on the Cardlytics Investor Relations website at ir.cardlytics.com, or by registering at this link. Following the call, a replay will be available on the website. Dial-in: Call participants may dial +1 800-549-8228 and use Conference ID: 86123. About Cardlytics Cardlytics (NASDAQ: CDLX) is a commerce media platform, powered by our publishers' first-party purchase data, that makes commerce smarter and more rewarding for everyone. We offer a range of solutions to help advertisers and publishers, including financial institutions, grow and strengthen customer loyalty. With visibility into approximately half of all card-based transactions in the U.S. and a quarter in the U.K....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Das nackte Kind, das zagt nicht; mit seinem Pfennig springt es fort und kennt recht gut den Sammelort - ich meine des Bäckers Laden. - Johann Wolfgang von Goethe
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!